No Data
No Data
Pharmaron Beijing Reports Share Repurchase
Kanglong Chemical (03759.HK) spent 16.616 million yuan to buy back 762,200 A shares on May 21
Kanglong Chemical (03759.HK) announced that it spent 16.616 million yuan to buy back 762,200 A shares on May 21.
Kanglong Chemical (300759): Strengthening cash flow from the sale of overseas equity participation
Key Investment Companies sell shares in overseas participating companies, and we expect to make a positive contribution to the profit side in 2024. Event: Sale of PROTEOLOGIX Shares, Cash Flow Enhancement May 17 Company Announcement: PROTEO
Improve quality and expand! The National Health Insurance Administration issued a new collection document “There is a lot of information” to set the tone for new trends in collection and procurement
① Yesterday evening, the National Health Insurance Administration issued the “Notice on Strengthening Regional Collaboration to Improve Quality and Expand Centralized Pharmaceutical Procurement in 2024", which provides further instructions on “improving quality and expansion” of collection; ② Many interprovincial alliance procurement will soon be upgraded to national joint procurement, which has attracted strong attention from the industry. In particular, the provinces covered by the Sanming Alliance and Henan Alternative Medicine Alliance will be further expanded, and proprietary Chinese medicine and Chinese medicine tablet companies need to prepare early.
Intraday Overview | The three major indices fell sharply, and the science index fell more than 3%; auto stocks and pharmaceutical outsourcing concept stocks weakened; after ideal car performance, it plummeted nearly 20%
The Hang Seng Index fell 2.2%, and the Tech Net Index fell by 3.41%; most of the shares fell by more than 7%, JD Health and NIO by more than 6%, Bilibili by more than 5%, and Tencent, Ali, Baidu, and NetEase by more than 3%.
Kanglong Chemical (300759): Selling shares in overseas participating companies for about US$102.1 million is expected to increase net profit for 24 years
On May 16, Johnson & Johnson announced that it would acquire Proteologix with an all-cash payment of US$850 million, while possibly making additional milestone payments in the future. Kang Longxiang
No Data